Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Otake

Showing results (101-110 of 111) with videos related to

Pageof 12
Sort By:
The Journal of Antibiotics|January 1, 1983
Studies on the biosynthesis of bialaphos (SF-1293). 2. Isolation of the first natural products with a C-P-H bond and their involvement in the C-P-C bond formationH Seto, T Sasaki, S Imai, et al.
The Journal of Antibiotics|May 1, 1985
Studies on the biosynthesis of bialaphos (SF-1293). 6. Production of N-acetyl-demethylphosphinothricin and N-acetylbialaphos by blocked mutants of Streptomyces hygroscopicus SF-1293 and their roles in the biosynthesis of bialaphosS Imai, H Seto, T Sasaki, et al.
British Journal of Cancer|March 31, 2005
Altered expression of topoisomerase IIalpha contributes to cross-resistant to etoposide K562/MX2 cell line by aberrant methylationT Asano, K Nakamura, H Fujii, et al.
Gan|October 1, 1983
Potentiation of mitomycin C, 6-mercaptopurine, bleomycin, cis-diamminedichloroplatinum and 5-fluorouracil by mycotrienins and mycotrienolsM Kuwano, K Ikezaki, K Mamizuka, et al.
The Journal of Antibiotics|November 1, 1994
Antitumor activity of SPM VIII, a derivative of the nucleoside antibiotic spicamycin, against human tumor xenograftsM Kamishohara, H Kawai, A Odagawa, et al.
The Journal of Antibiotics|July 1, 1987
New morpholino anthracyclines, MX, MX2, and MY5H Umezawa, S Nakajima, H Kawai, et al.
Clinical Therapeutics|July 1, 1990
Effects of a new calcium channel blocker, TA 3090, on serum lipoprotein levels in mild to moderate essential hypertensionJ Sasaki, M Ideishi, K Saku, et al.
The Journal of Antibiotics|November 1, 1984
Studies on the biosynthesis of bialaphos (SF-1293). 5. Production of 2-phosphinomethylmalic acid, an analogue of citric acid by Streptomyces hygroscopicus SF-1293 and its involvement in the biosynthesis of bialaphosH Seto, S Imai, T Sasaki, et al.
The Journal of Antibiotics|September 1, 1993
Structure-antitumor activity relationship of semi-synthetic spicamycin analoguesM Kamishohara, H Kawai, A Odagawa, et al.
Bioscience, Biotechnology, and Biochemistry|November 1, 1995
Costunolide and dehydrocostus lactone as inhibitors of killing function of cytotoxic T lymphocytesM Taniguchi, T Kataoka, H Suzuki, et al.
Pageof 12

Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
The Journal of Antibiotics|January 1, 1983
Studies on the biosynthesis of bialaphos (SF-1293). 2. Isolation of the first natural products with a C-P-H bond and their involvement in the C-P-C bond formationH Seto, T Sasaki, S Imai, et al.
The Journal of Antibiotics|May 1, 1985
Studies on the biosynthesis of bialaphos (SF-1293). 6. Production of N-acetyl-demethylphosphinothricin and N-acetylbialaphos by blocked mutants of Streptomyces hygroscopicus SF-1293 and their roles in the biosynthesis of bialaphosS Imai, H Seto, T Sasaki, et al.
British Journal of Cancer|March 31, 2005
Altered expression of topoisomerase IIalpha contributes to cross-resistant to etoposide K562/MX2 cell line by aberrant methylationT Asano, K Nakamura, H Fujii, et al.
Gan|October 1, 1983
Potentiation of mitomycin C, 6-mercaptopurine, bleomycin, cis-diamminedichloroplatinum and 5-fluorouracil by mycotrienins and mycotrienolsM Kuwano, K Ikezaki, K Mamizuka, et al.
The Journal of Antibiotics|November 1, 1994
Antitumor activity of SPM VIII, a derivative of the nucleoside antibiotic spicamycin, against human tumor xenograftsM Kamishohara, H Kawai, A Odagawa, et al.
The Journal of Antibiotics|July 1, 1987
New morpholino anthracyclines, MX, MX2, and MY5H Umezawa, S Nakajima, H Kawai, et al.
Clinical Therapeutics|July 1, 1990
Effects of a new calcium channel blocker, TA 3090, on serum lipoprotein levels in mild to moderate essential hypertensionJ Sasaki, M Ideishi, K Saku, et al.
The Journal of Antibiotics|November 1, 1984
Studies on the biosynthesis of bialaphos (SF-1293). 5. Production of 2-phosphinomethylmalic acid, an analogue of citric acid by Streptomyces hygroscopicus SF-1293 and its involvement in the biosynthesis of bialaphosH Seto, S Imai, T Sasaki, et al.
The Journal of Antibiotics|September 1, 1993
Structure-antitumor activity relationship of semi-synthetic spicamycin analoguesM Kamishohara, H Kawai, A Odagawa, et al.
Bioscience, Biotechnology, and Biochemistry|November 1, 1995
Costunolide and dehydrocostus lactone as inhibitors of killing function of cytotoxic T lymphocytesM Taniguchi, T Kataoka, H Suzuki, et al.
Pageof 12